Rockwell Medical Projects Net Sales To Grow In The Mid-to-high Single Digits In 2025 And Beyond, And Gross Margin In 2025 To Be Approximately 20% And Reaching Above 25% In 2026 And Beyond
Portfolio Pulse from Benzinga Newsdesk
Rockwell Medical (RMTI) has updated its 2024 guidance, projecting net sales between $95.0M and $98.0M, gross profit between $14.0M and $16.0M, and adjusted EBITDA between $0.75M and $1.5M. The company also projects net sales growth in the mid-to-high single digits in 2025 and beyond, with gross margins reaching approximately 20% in 2025 and above 25% in 2026 and beyond.
August 08, 2024 | 10:05 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rockwell Medical (RMTI) has updated its 2024 guidance, showing improved projections for net sales, gross profit, and adjusted EBITDA. The company also forecasts strong growth in 2025 and beyond.
The updated guidance indicates improved financial performance for 2024, with higher net sales, gross profit, and adjusted EBITDA. The projections for strong growth in 2025 and beyond are likely to positively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100